September 25-26, 2017, NIH, Rockville, MD

Understanding the Role of Muscle and Body Composition in Studies of Cancer Risk and Prognosis in Cancer Survivors


Overview

The National Cancer Institute's Epidemiology and Genomics Research Program (EGRP) is hosting a workshop, "Understanding the Role of Muscle and Body Composition in Studies of Cancer Risk and Prognosis in Cancer Survivors," September 25-26, 2017, in the NIH Conference Center at 5635 Fishers Lane in Rockville, MD.

The purpose of this workshop is to bring together scientists to discuss current research examining how body composition affects cancer outcomes and identify the research needed to inform recommendations for cancer survivors. The workshop will also identify key methodological challenges and approaches to optimize measurement and analysis, building on past examples studying sarcopenia, cachexia, and frailty in aging populations, to better understand the implications for cancer survivors.

Return to Top

Agenda


View agenda for Monday, September 25
Time Topic
8:30 a.m. - 9:00 a.m. Registration
9:00 a.m. - 9:30 a.m.

Welcome
Joanne Elena, Ph.D., M.P.H.
National Cancer Institute

9:30 a.m. - 10:00 a.m.

Evidence of the import of sarcopenia and other measures of body composition on cancer survival
Bette Caan, Dr.P.H.
Kaiser Permanente Northern California

10:00 a.m. - 10:30 a.m.

Body composition and adverse outcomes in cancer survivors: a review of suggested explanations
Shlomit Strulov Shachar, M.D.
University of North Carolina at Chapel Hill

10:30 a.m. - 10:45 a.m. Discussion
10:45 a.m. - 11:00 a.m. Break
11:00 a.m. - 11:20 a.m.

Lean mass and muscle physiology
Luigi Ferrucci, M.D., Ph.D.
National Institute on Aging

11:20 a.m. - 11:40 a.m.

Fatty infiltration into muscle and fibrotic tissue in adipose tissue: its relation to inflammation
Tamara Harris, M.D., M.S.
National Institute on Aging

11:40 a.m. - 12:00 p.m.

Breast adipose inflammation: a silent killer
Andrew Dannenberg, M.D.
Cornell University

12:00 p.m. - 12:15 p.m. Discussion
12:15 p.m. - 1:15 p.m. Poster Session and Lunch (Cafeteria on site)
1:15 p.m. - 1:35 p.m.

Will current data-driven approaches/background of sarcopenia help us?
Peggy M. Cawthon, Ph.D., M.P.H.
University of California San Francisco and California Pacific Medical Center

1:35 p.m. - 1:55 p.m.

Different cutpoints/landmarks: finding meaningful cutpoints to predict those at risk for poor outcomes
Vickie Baracos, Ph.D.
University of Alberta

1:55 p.m. - 2:15 p.m.

Measuring function in cancer patients with sarcopenia: do we need disease- or sarcopenic-specific measures?
Linda Woodhouse, Ph.D.
University of Alberta

2:15 p.m. - 2:35 p.m.

Applying what we've learned from clinical trials about cachexia to cancer survivors
Jeffrey Crawford, M.D.
Duke Cancer Institute

2:35 p.m. - 3:00 p.m. Panel Discussion
3:00 p.m. - 3:15 p.m. Break
3:15 p.m. - 3:45 p.m.

Overview of methods/considerations in assessment. How does sarcopenia differ from cachexia? What are the methods for assessing brown/beige fat, timing of imaging and more?
Steven Heymsfield, M.D.
Louisiana State University

3:45 p.m. - 4:10 p.m.

DXA new functions and algorithms for lean mass: experimenting with different approaches
John Shepherd, Ph.D., C.C.D.
University of California San Francisco

4:10 p.m. - 4:35 p.m.

Measuring body composition/sarcopenia in large studies: appropriate and feasible methods
June Stevens, Ph.D.
University of North Carolina at Chapel Hill

4:35 p.m. - 5:00 p.m.

Using ultrasound technology to measure sarcopenia
Marina Mourtzakis, Ph.D.
University of Waterloo

5:00 p.m. - 5:30 p.m. Panel Discussion

View agenda for Tuesday, September 26
Time Topic
8:30 a.m. - 8:45 a.m.

Welcome
Joanne Elena, Ph.D., M.P.H.
National Cancer Institute

8:45 a.m. - 9:10 a.m.

Nutritional interventions: optimal strategies for reducing adiposity while maintaining muscle mass
Carla Prado, Ph.D., R.D.
University of Alberta

9:10 a.m. – 9:35 a.m.

Exercise therapy to improve muscle quantity and quality in cancer survivors
Jessica Scott, Ph.D.
Memorial Sloan Kettering Cancer Center

9:35 a.m. – 10:00 a.m.

Where are the gaps? What research do we need to inform guidelines for clinicians?
Wendy Chen, M.D., M.P.H.
Harvard University

10:00 a.m. – 10:30 a.m. Discussion
10:30 a.m. - 10:40 a.m. Break
10:45 a.m. – 12:00 p.m.

Setting Priorities for Future Directions of Research Panel Discussion
Steven Heymsfield, M.D., Louisiana State University
Bette Caan, Dr.P.H., Kaiser Permanente Northern California
Shlomit Strulov Shachar, M.D., University of North Carolina at Chapel Hill
Tamara Harris, M.D., M.S., National Institute on Aging
Carla Prado, Ph.D., R.D., University of Alberta
Lisa Gallicchio, Ph.D., National Cancer Institute

12:00 p.m. – 1:00 p.m. Working Lunch (Cafeteria on site)
1:00 p.m. – 2:30 p.m.

Audience Input for Future Directions of Research
Opportunity for meeting attendees to discuss the gaps in research and identify key future directions to better understand the role of body composition in cancer outcomes. A summary of this discussion will be reflected in the final meeting report.

2:30 p.m. – 3:00 p.m.

Wrap up/Adjourn
Joanne Elena, Ph.D., M.P.H.
National Cancer Institute


Return to Top

Registration

This Workshop is free to attend, but registration is required. Registrants who cannot attend in person should choose the "Webinar" option on the registration page.

Note: NCI is using Eventbrite for the event registration. To register, you may be required to provide Personally Identifiable Information (PII) so that the NCI event management staff may contact you with details pertaining to the event. PII could include your name and email address. NCI staff does not disclose any information about people who register for NCI events. (See Eventbrite Privacy PolicyExternal Web Site Policy).

Return to Top

Planning Committee

Return to Top

Contact

For further information or questions, contact Joanne Elena, Ph.D., M.P.H., Program Director, Clinical and Translational Epidemiology Branch, Epidemiology and Genomics Research Program, NCI.

Return to Top